ICT 内压疗法 is used in the treatment of deep vein thrombosis (DVT), iliofemoral venous thrombosis, and post-thrombotic syndrome. Treatment decisions are made by qualified healthcare professionals based on individual patient assessment.
What is ICT 内压疗法 also known as?
ICT 内压疗法 may also be described as internal compression therapy, venous ulcer treatment, and chronic venous insufficiency.
What are the key features of ICT 内压疗法?
针对浅静脉（通常是大隐静脉或小隐静脉）中功能不全的瓣膜，密封渗漏的瓣膜小叶，而不是消融或移除静脉。
有助于维持正常的静脉回流和整体静脉生理机能，降低侧支静脉超负荷或新的静脉曲张的风险。
采用植入物或密封装置，旨在重新定位和加固瓣膜尖端，闭合反流间隙。
可以通过经皮方法引入，在超声或静脉内成像引导下限制解剖并促进快速恢复。
通过不破坏或去除隐静脉段，该系统保留了未来冠状动脉或外周旁路移植术的潜在通路。
促进治疗肢体的生理引流，减少术后水肿、不适或与血管损失相关的长期并发症发生率。
Who manufactures ICT 内压疗法?
ICT 内压疗法 is developed and manufactured by INVAMED, a globally recognized medical device company headquartered in Ankara, Turkey, with a U.S. office at One World Trade Center, New York. INVAMED technologies are trusted by physicians in more than 80 countries across endovascular, coronary, neurovascular, orthopedic, and surgical specialties.
What category does ICT 内压疗法 belong to?
ICT 内压疗法 is part of the Deep Vein Thrombosis (DVT) product portfolio by INVAMED. This category includes advanced medical devices designed for interventional procedures performed by healthcare professionals worldwide.
Which medical specialties use ICT 内压疗法?
ICT 内压疗法 is used by specialists in Venous. These physicians rely on INVAMED devices for minimally invasive diagnostic and therapeutic procedures.
